Edward W. Boyer, MD, PhD, medical toxicologist, The Ohio State University, shares his thoughts on possible reasons why residents in East Palestine, Ohio, are reporting smelling chemicals, feeling ill, and developing rashes.
Individuals with adverse symptoms were most likely exposed to chemicals from the train derailment, but one should also consider other possibilties, such as the "nocebo" effect, says Edward Boyer, MD, PhD, medical toxicologist, emergency medicine physician, and professor of emergency medicine at The Ohio State University..
Transcript
Could toxic exposure from the train derailment in Ohio be causing residents to smell chemicals, feel ill, or develop rashes?
It's difficult to say. I want to be very clear in what I'm about to say here. These individuals likely were exposed; the exposure is known. There was a wonderful paper in The New England Journal of Medicine many years ago, which I think highlighted the value of the nocebo effect, but also provided some indication of how the nocebo effect can manifest after a toxic exposure.
The nocebo effect is: If I tell you that I'm going to do something to you that's very, very painful, your perception of pain is actually going to be greater than if I told you this is not going to be a painful procedure whatsoever. The New England Journal of Medicine publication from several years ago is a little bit different. There was no exposure that happened there. And exposure happened in East Palestine, Ohio—so I want to make sure that I highlight the differences.
But the title of the New England Journal paper was “Mass Psychogenic Illness” in a Tennessee high school. The interesting thing about it was that it started off with, I believe, a teacher saying that she smelled something bad. Then other people smelled bad things. Pretty soon, there were large numbers of individuals who developed complaints. Everybody was sent home, nobody would go back into the building, the Centers for Disease Control did a very deep dive into everything in this school and found absolutely nothing. So again, to highlight the difference, there was no exposure at this Tennessee School, there was exposure in East Palestine, Ohio. But that provides us with some information on how we should move forward.
Individuals who have rashes should see a dermatologist so that an independent objective observer can see the rash for themselves and determine if it's potentially associated with a chemical exposure vs something else. For people who experience chemical smells, I can see why there's a chemical smell there in East Palestine, Ohio. They burned off tons of material, so I have no doubt that there could be a smell lingering around the town.
But the take home message here is that if there is a medical complaint, if there is a cough, shortness of breath, rash, headache, abdominal pain, it's important to see an expert so that independent objective testing can be done. Because in the Tennessee case, every complaint that people had was purely subjective and not validated, or at least not verified by anybody in almost real time. Even the rashes couldn't be observed by anybody independently.
It pays—because we don't know what we're looking for necessarily after exposure—to cast a wide net and have people see their physician, have people referred to a specialist if their physician cannot or lacks the clinical expertise to evaluate a condition, and then move forward from there.
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment
April 4th 2025Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.
Read More
Bridging Education Gaps in Treatment for Scarring Alopecia With Innovative Approaches
March 28th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of understanding inflammatory pathways for developing targeted therapies.
Read More